E. Felip , C.I. Rojas , M. Schenker , D.M. Kowalski , I.A. Casarini , T. Csoszi , M.A.N. Sendur , J. Martins , A. Calles Blanco , C.C. Wang , X. Song , R.A. Ramırez Fallas , H. Yoshioka , S. Nair , M. Wang , X. Deng , M. Lala , R. Eiras , T. Takahashi
{"title":"8MO:转移性非小细胞肺癌(mNSCLC)的皮下(SC)与静脉(IV)派姆单抗(pembrolizumab)加化疗(CT): III期MK-3475A-D77试验","authors":"E. Felip , C.I. Rojas , M. Schenker , D.M. Kowalski , I.A. Casarini , T. Csoszi , M.A.N. Sendur , J. Martins , A. Calles Blanco , C.C. Wang , X. Song , R.A. Ramırez Fallas , H. Yoshioka , S. Nair , M. Wang , X. Deng , M. Lala , R. Eiras , T. Takahashi","doi":"10.1016/S1556-0864(25)00203-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S12-S13"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"8MO: Subcutaneous (SC) versus intravenous (IV) pembrolizumab (Pembro) plus chemotherapy (CT) in metastatic non-small cell lung cancer (mNSCLC): Phase III MK-3475A-D77 trial\",\"authors\":\"E. Felip , C.I. Rojas , M. Schenker , D.M. Kowalski , I.A. Casarini , T. Csoszi , M.A.N. Sendur , J. Martins , A. Calles Blanco , C.C. Wang , X. Song , R.A. Ramırez Fallas , H. Yoshioka , S. Nair , M. Wang , X. Deng , M. Lala , R. Eiras , T. Takahashi\",\"doi\":\"10.1016/S1556-0864(25)00203-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"20 3\",\"pages\":\"Pages S12-S13\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086425002035\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425002035","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
8MO: Subcutaneous (SC) versus intravenous (IV) pembrolizumab (Pembro) plus chemotherapy (CT) in metastatic non-small cell lung cancer (mNSCLC): Phase III MK-3475A-D77 trial
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.